Your browser doesn't support javascript.
loading
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045.
Kim, Yoo-Na; Joung, Je-Gun; Park, Eunhyang; Kim, Jae-Weon; Lee, Jung Bok; Lim, Jinyeong; Kim, Sunghoon; Choi, Chel Hun; Kim, Hee Seung; Chung, Jongsuk; Kim, Byoung-Gie; Lee, Jung-Yun.
Afiliação
  • Kim YN; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, South Korea.
  • Joung JG; Department of Biomedical Science, College of Life Science, CHA University, Seongnam, South Korea.
  • Park E; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee JB; Department of Clinical Epidemiology & Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Lim J; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, South Korea.
  • Kim S; Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.
  • Choi CH; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim HS; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Chung J; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim BG; Geninus Inc, Seoul, South Korea.
  • Lee JY; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, South Korea.
Int J Cancer ; 153(12): 2032-2044, 2023 12 15.
Article em En | MEDLINE | ID: mdl-37602928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul